SUCCINYLCHOLINE CHLORIDE

SUCCINYLCHOLINE CHLORIDE was reported 2257 times

SUCCINYLCHOLINE CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOCHOLINESTERASE DEFICIENCY 24 0.3692
1 BRACHIAL PULSE ABNORMAL 1 0.3333
2 SCHIZENCEPHALY 11 0.2444
3 BLOOD CHOLINESTERASE ABNORMAL 2 0.2000
4 CEREBRAL HAEMORRHAGE FOETAL 11 0.1803
5 ECHOENCEPHALOGRAM ABNORMAL 1 0.1667
6 TRACHEAL DEVIATION 9 0.1023
7 ADMINISTRATION SITE PAPULE 1 0.1000
8 INTUBATION COMPLICATION 5 0.0980
9 NEUROMUSCULAR BLOCK PROLONGED 35 0.0949
10 OBSTETRICAL PULMONARY EMBOLISM 2 0.0870
11 TRIGEMINO-CARDIAC REFLEX 6 0.0741
12 PIGMENT NEPHROPATHY 6 0.0674
13 HYPERTHERMIA MALIGNANT 98 0.0658
14 END-TIDAL CO2 INCREASED 3 0.0652
15 NEUROMUSCULAR BLOCKING THERAPY 2 0.0606
16 ANGIOGRAM CEREBRAL ABNORMAL 1 0.0588
17 NEGATIVE PRESSURE PULMONARY OEDEMA 5 0.0510
18 NERVE STIMULATION TEST ABNORMAL 2 0.0488
19 RENAL ISCHAEMIA 26 0.0475
20 HAEMODYNAMIC TEST ABNORMAL 3 0.0448
21 CAROTID PULSE DECREASED 2 0.0444
22 ANAESTHETIC COMPLICATION CARDIAC 3 0.0435
23 PO2 INCREASED 22 0.0434
24 PHRENIC NERVE PARALYSIS 9 0.0411
25 PCO2 INCREASED 29 0.0407
26 HYPOVENTILATION NEONATAL 3 0.0395
27 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV 1 0.0357
28 ANAESTHETIC COMPLICATION PULMONARY 3 0.0337
29 FEMORAL PULSE DECREASED 1 0.0323
30 AGITATION POSTOPERATIVE 2 0.0317
31 NEUROMUSCULAR BLOCKADE 7 0.0312
32 AIRWAY COMPLICATION OF ANAESTHESIA 8 0.0304
33 FOETAL MALPRESENTATION 3 0.0278
34 MYOTONIA 6 0.0270
35 RED BLOOD CELL ELLIPTOCYTES PRESENT 2 0.0260
36 ACUTE FATTY LIVER OF PREGNANCY 1 0.0250
37 RADIAL PULSE ABNORMAL 3 0.0248
38 BURKHOLDERIA TEST POSITIVE 3 0.0242
39 UTERINE HYPOTONUS 3 0.0238
40 MATERNAL EXPOSURE DURING DELIVERY 23 0.0232
41 CARDIAC INDEX INCREASED 1 0.0227
42 LONG QT SYNDROME CONGENITAL 2 0.0222
43 END-TIDAL CO2 DECREASED 1 0.0213
44 CARDIO-RESPIRATORY DISTRESS 6 0.0210
45 APNOEA TEST ABNORMAL 1 0.0208
46 DELAYED RECOVERY FROM ANAESTHESIA 19 0.0200
47 DRUG EFFECT PROLONGED 11 0.0199
48 PRODUCT DESIGN CONFUSION 2 0.0194
49 BASE EXCESS 1 0.0192
50 APGAR SCORE ABNORMAL 2 0.0189
51 PHAEOCHROMOCYTOMA CRISIS 4 0.0189
52 RESPIRATORY PARALYSIS 3 0.0187
53 SOMATOFORM DISORDER 4 0.0183
54 ENDOTRACHEAL INTUBATION COMPLICATION 10 0.0169
55 CIRCULATORY FAILURE NEONATAL 1 0.0169
56 BLOOD PH DECREASED 29 0.0169
57 VENTRICULAR TACHYARRHYTHMIA 5 0.0157
58 CHEST WALL RIGIDITY 1 0.0156
59 IRIDOCELE 2 0.0154
60 UTERINE ATONY 4 0.0153
61 UNWANTED AWARENESS DURING ANAESTHESIA 5 0.0152
62 POSTOPERATIVE DELIRIUM 3 0.0152
63 MYOGLOBINURIA 8 0.0150
64 DIABETES INSIPIDUS 36 0.0149
65 FIBRINOLYSIS 1 0.0147
66 BLOOD CHOLINESTERASE DECREASED 4 0.0146
67 CRITICAL ILLNESS POLYNEUROPATHY 1 0.0145
68 LENS DISLOCATION 3 0.0143
69 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
70 BLOOD BICARBONATE DECREASED 26 0.0137
71 OPERATIVE HAEMORRHAGE 6 0.0134
72 THERAPEUTIC PRODUCT EFFECT PROLONGED 6 0.0132
73 ALLERGY TEST NEGATIVE 2 0.0128
74 URINOMA 2 0.0127
75 RHYTHM IDIOVENTRICULAR 4 0.0123
76 ANAEMIA OF PREGNANCY 2 0.0116
77 UTERINE HYPERTONUS 3 0.0111
78 ALLERGY TEST POSITIVE 5 0.0110
79 DUCHENNE MUSCULAR DYSTROPHY 1 0.0108
80 BRONCHIAL OEDEMA 1 0.0106
81 ANAPHYLACTOID SHOCK 5 0.0106
82 ANAPHYLACTOID SYNDROME OF PREGNANCY 1 0.0104
83 ANAESTHETIC COMPLICATION 28 0.0104
84 ANAL POLYP 1 0.0097
85 OXYGEN SATURATION ABNORMAL 27 0.0095
86 ANAL EROSION 1 0.0091
87 NEONATAL RESPIRATORY DEPRESSION 3 0.0090
88 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
89 FOETAL EXPOSURE DURING DELIVERY 6 0.0088
90 SEIZURE LIKE PHENOMENA 15 0.0088
91 ALBUMIN GLOBULIN RATIO DECREASED 2 0.0086
92 FOETAL HEART RATE DECELERATION 2 0.0086
93 APGAR SCORE LOW 11 0.0085
94 BRADYCARDIA FOETAL 7 0.0084
95 PROCEDURAL HYPOTENSION 7 0.0082
96 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
97 ABDOMINAL WALL CYST 1 0.0082
98 PRODUCT MEASURED POTENCY ISSUE 8 0.0079
99 CYSTATIN C INCREASED 1 0.0078
100 MYOCARDIAL DEPRESSION 2 0.0078
101 DRUG INTERACTION POTENTIATION 2 0.0078
102 ANAESTHETIC COMPLICATION NEUROLOGICAL 7 0.0077
103 EPIGLOTTIC OEDEMA 2 0.0076
104 BLOOD GASES ABNORMAL 4 0.0074
105 POSTOPERATIVE FEVER 2 0.0071
106 CRUSH SYNDROME 1 0.0071
107 DECEREBRATE POSTURE 1 0.0068
108 CARDIAC OUTPUT DECREASED 6 0.0068
109 FOETAL DEATH 35 0.0067
110 ALLERGIC TRANSFUSION REACTION 1 0.0066
111 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
112 BLOOD CREATININE 1 0.0065
113 CEREBRAL HYPOPERFUSION 3 0.0064
114 BLOOD OSMOLARITY INCREASED 2 0.0061
115 MYASTHENIA GRAVIS CRISIS 9 0.0061
116 HYPORESPONSIVE TO STIMULI 7 0.0060
117 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
118 PNEUMONITIS ASPIRATION 2 0.0058
119 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0057
120 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 19 0.0057
121 PSEUDOMONAL SEPSIS 10 0.0057
122 ANAPHYLACTIC SHOCK 147 0.0057
123 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
124 TRYPTASE INCREASED 4 0.0056
125 SYMPTOM MASKED 4 0.0055
126 CLONUS 15 0.0055
127 BRADYARRHYTHMIA 9 0.0055
128 APNOEA 42 0.0054
129 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
130 SKIN TEST POSITIVE 5 0.0054
131 HYPOCOAGULABLE STATE 5 0.0051
132 DEAFNESS PERMANENT 1 0.0051
133 STRIDOR 15 0.0051
134 PRODUCT LABEL ON WRONG PRODUCT 2 0.0051
135 FOETAL HEART RATE DECREASED 3 0.0048
136 HYPOCAPNIA 2 0.0048
137 ELECTROENCEPHALOGRAM ABNORMAL 15 0.0047
138 CHOLINERGIC SYNDROME 3 0.0047
139 HYPERCAPNIA 14 0.0046
140 RESPIRATORY ACIDOSIS 18 0.0046
141 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
142 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
143 DYSPHASIA 2 0.0043
144 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
145 BUTTOCK PAIN 1 0.0042
146 BRONCHOSPASM 60 0.0042
147 DISSOCIATIVE DISORDER 3 0.0042
148 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
149 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
150 PCO2 DECREASED 4 0.0041
151 AREFLEXIA 11 0.0041
152 PNEUMONIA HAEMOPHILUS 2 0.0041
153 LARYNGOSPASM 11 0.0041
154 PREMATURE SEPARATION OF PLACENTA 6 0.0039
155 MYASTHENIC SYNDROME 3 0.0039
156 HYPERMETABOLISM 2 0.0038
157 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
158 ELECTROMECHANICAL DISSOCIATION 3 0.0038
159 CARDIAC FAILURE CHRONIC 16 0.0038
160 LONG QT SYNDROME 9 0.0037
161 PROCEDURAL NAUSEA 3 0.0037
162 HYPOGLYCAEMIA NEONATAL 6 0.0037
163 ANTITHROMBIN III DECREASED 1 0.0037
164 PILOERECTION 4 0.0037
165 EAR NEOPLASM 1 0.0036
166 VENTRICULAR TACHYCARDIA 60 0.0036
167 FOETAL MACROSOMIA 1 0.0036
168 FEAR OF DEATH 8 0.0036
169 APNOEIC ATTACK 2 0.0035
170 APPENDICITIS PERFORATED 9 0.0035
171 CARBUNCLE 1 0.0035
172 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
173 COMPLICATION OF DELIVERY 1 0.0035
174 PREMATURE LABOUR 19 0.0034
175 MEAN PLATELET VOLUME INCREASED 2 0.0033
176 MUCOSAL EROSION 3 0.0033
177 BLOOD MAGNESIUM DECREASED 28 0.0032
178 FEAR 87 0.0032
179 MULTI-ORGAN FAILURE 55 0.0032
180 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5 0.0032
181 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
182 PROCEDURAL VOMITING 2 0.0031
183 PAROTID GLAND ENLARGEMENT 2 0.0031
184 HYPERMAGNESAEMIA 2 0.0031
185 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
186 DYSTHYMIC DISORDER 1 0.0030
187 POSTPARTUM HAEMORRHAGE 4 0.0030
188 OESOPHAGITIS ULCERATIVE 2 0.0029
189 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
190 STRESS CARDIOMYOPATHY 17 0.0029
191 PRODUCT PACKAGING CONFUSION 7 0.0029
192 FUNGAL TEST POSITIVE 1 0.0028
193 ANOXIA 1 0.0028
194 NEONATAL ASPHYXIA 2 0.0028
195 HYPOVENTILATION 9 0.0028
196 APALLIC SYNDROME 2 0.0028
197 ANKLE ARTHROPLASTY 1 0.0028
198 ABSCESS BACTERIAL 1 0.0028
199 ANAESTHESIA 1 0.0027
200 PULSE ABSENT 13 0.0027
201 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 3 0.0027
202 ECLAMPSIA 1 0.0027
203 TRISMUS 14 0.0027
204 RESPIRATORY TRACT OEDEMA 2 0.0027
205 CORNEAL REFLEX DECREASED 1 0.0027
206 BLOOD CALCIUM DECREASED 30 0.0027
207 BLOODY DISCHARGE 3 0.0026
208 CARBON DIOXIDE DECREASED 3 0.0026
209 ADMINISTRATION SITE REACTION 1 0.0026
210 GASTROINTESTINAL ANASTOMOTIC LEAK 1 0.0026
211 METAPNEUMOVIRUS INFECTION 2 0.0026
212 OPISTHOTONUS 2 0.0025
213 ANHEDONIA 66 0.0025
214 BRAIN COMPRESSION 1 0.0025
215 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
216 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
217 GENITAL ABSCESS 1 0.0025
218 INCISION SITE HAEMORRHAGE 2 0.0025
219 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
220 RENAL INJURY 73 0.0025
221 MUSCLE RIGIDITY 29 0.0024
222 NEONATAL HYPOXIA 2 0.0024
223 TACHYARRHYTHMIA 6 0.0024
224 CANDIDA TEST POSITIVE 1 0.0024
225 PARALYSIS 34 0.0024
226 PYLORIC STENOSIS 2 0.0024
227 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
228 SEROTONIN SYNDROME 44 0.0023
229 VASOCONSTRICTION 2 0.0023
230 UPPER AIRWAY OBSTRUCTION 2 0.0023
231 VENTRICULAR FIBRILLATION 25 0.0022
232 GENERAL ANAESTHESIA 1 0.0022
233 STATUS EPILEPTICUS 25 0.0022
234 AIR EMBOLISM 1 0.0021
235 ANAPHYLACTIC REACTION 114 0.0021
236 CARDIAC ARREST 169 0.0020
237 SUBCUTANEOUS EMPHYSEMA 2 0.0020
238 NORMAL NEWBORN 11 0.0020
239 RHABDOMYOLYSIS 83 0.0020
240 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
241 CAESAREAN SECTION 23 0.0020
242 SINUS BRADYCARDIA 19 0.0020
243 BLOOD PRESSURE IMMEASURABLE 3 0.0020
244 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
245 CONVULSION NEONATAL 1 0.0019
246 RESPIRATORY DEPRESSION 23 0.0019
247 VASOPLEGIA SYNDROME 3 0.0018
248 METABOLIC SYNDROME 3 0.0018
249 RESUSCITATION 3 0.0018
250 HYPOTONIA 18 0.0018
251 THERAPEUTIC AGENT TOXICITY 6 0.0018
252 FACIAL SPASM 2 0.0018
253 BODY TINEA 1 0.0018
254 ENCEPHALOMALACIA 1 0.0018
255 POST PROCEDURAL COMPLICATION 34 0.0018
256 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
257 PO2 DECREASED 2 0.0017
258 METHAEMOGLOBINAEMIA 4 0.0017
259 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
260 PROCEDURAL COMPLICATION 13 0.0017
261 CARDIAC PROCEDURE COMPLICATION 1 0.0016
262 TETANY 3 0.0016
263 CONDUCTION DISORDER 3 0.0016
264 BLOOD BILIRUBIN DECREASED 1 0.0016
265 RESPIRATORY RATE DECREASED 5 0.0016
266 BREECH PRESENTATION 2 0.0016
267 ACIDOSIS 12 0.0016
268 SEDATION COMPLICATION 4 0.0016
269 INCREASED BRONCHIAL SECRETION 4 0.0016
270 CYANOSIS NEONATAL 1 0.0016
271 ANOXIC ENCEPHALOPATHY 1 0.0016
272 HYPERKALAEMIA 54 0.0015
273 CHONDROCALCINOSIS 1 0.0015
274 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
275 CIRCULATORY COLLAPSE 26 0.0015
276 VOCAL CORD DISORDER 3 0.0015
277 LOW BIRTH WEIGHT BABY 12 0.0015
278 ANION GAP INCREASED 2 0.0015
279 ISCHAEMIC HEPATITIS 2 0.0015
280 CYTOKINE STORM 1 0.0015
281 CEREBRAL CYST 1 0.0015
282 DEATH NEONATAL 2 0.0014
283 INJURY 101 0.0014
284 FOETAL HYPOKINESIA 1 0.0014
285 FLUID IMBALANCE 1 0.0014
286 HYPOXIA 50 0.0014
287 DERMATITIS DIAPER 1 0.0014
288 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
289 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
290 CERVICAL RADICULOPATHY 1 0.0014
291 BRADYCARDIA 74 0.0014
292 LYMPHOCYTOSIS 3 0.0014
293 ANTIBODY TEST ABNORMAL 1 0.0014
294 MUTISM 2 0.0014
295 CLONIC CONVULSION 1 0.0014
296 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
297 COMA HEPATIC 1 0.0013
298 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
299 TACHYPNOEA 18 0.0013
300 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
301 HAEMODYNAMIC INSTABILITY 10 0.0013
302 HYPERTHERMIA 10 0.0013
303 DIAPHRAGMATIC DISORDER 1 0.0013
304 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
305 CREATINE KINASE INCREASED 1 0.0013
306 COAGULATION TEST ABNORMAL 1 0.0013
307 TORSADE DE POINTES 10 0.0013
308 EYELID FUNCTION DISORDER 1 0.0013
309 NEONATAL DISORDER 2 0.0013
310 PREMATURE BABY 38 0.0013
311 RENAL IMPAIRMENT 106 0.0013
312 VENTRICULAR HYPOKINESIA 4 0.0012
313 DRUG EXPOSURE DURING PREGNANCY 42 0.0012
314 MYOCARDIAL ISCHAEMIA 14 0.0012
315 UNEVALUABLE EVENT 93 0.0012
316 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
317 OROPHARYNGEAL BLISTERING 2 0.0012
318 BREAST OPERATION 1 0.0012
319 ENCEPHALOPATHY 30 0.0012
320 DEAFNESS NEUROSENSORY 4 0.0012
321 DYSCHROMATOPSIA 1 0.0012
322 CSF PROTEIN INCREASED 1 0.0012
323 ADRENAL MASS 1 0.0012
324 UNRESPONSIVE TO STIMULI 31 0.0012
325 PRODUCT LABEL CONFUSION 7 0.0012
326 TROPONIN I INCREASED 2 0.0012
327 ADRENAL SUPPRESSION 1 0.0012
328 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
329 RESPIRATION ABNORMAL 8 0.0012
330 BLOOD CHLORIDE INCREASED 2 0.0012
331 ENDOCRINE OPHTHALMOPATHY 1 0.0012
332 TYPE I HYPERSENSITIVITY 4 0.0011
333 ENTEROCUTANEOUS FISTULA 1 0.0011
334 BRUXISM 6 0.0011
335 METABOLIC ACIDOSIS 35 0.0011
336 CERUMEN IMPACTION 1 0.0011
337 FOETAL HEART RATE ABNORMAL 1 0.0011
338 ENDOTRACHEAL INTUBATION 3 0.0011
339 BUNDLE BRANCH BLOCK 1 0.0011
340 MECHANICAL VENTILATION 2 0.0011
341 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
342 BLOOD URINE 1 0.0010
343 COMA SCALE ABNORMAL 3 0.0010
344 CONVERSION DISORDER 2 0.0010
345 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
346 PROCEDURAL HAEMORRHAGE 4 0.0010
347 MATERNAL EXPOSURE DURING PREGNANCY 91 0.0010
348 MYOCLONUS 12 0.0010
349 ARTERIOSPASM CORONARY 4 0.0010
350 ORGAN FAILURE 4 0.0010
351 BRAIN STEM INFARCTION 1 0.0010
352 BRAIN DEATH 3 0.0010
353 OLIGURIA 6 0.0010
354 ABORTION INDUCED 9 0.0010
355 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
356 LOOSE TOOTH 3 0.0009
357 HYPOTENSION 185 0.0009
358 GASTRIC BYPASS 2 0.0009
359 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
360 RENAL FAILURE 120 0.0009
361 NO THERAPEUTIC RESPONSE 11 0.0009
362 POTENTIATING DRUG INTERACTION 3 0.0009
363 ACUTE PULMONARY OEDEMA 5 0.0009
364 CATHETER RELATED COMPLICATION 1 0.0009
365 HEPATOCELLULAR DAMAGE 2 0.0009
366 BLOOD LOSS ANAEMIA 2 0.0009
367 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
368 KOUNIS SYNDROME 2 0.0009
369 GENERALISED ERYTHEMA 5 0.0009
370 PREMATURE DELIVERY 14 0.0009
371 ARTERIAL HAEMORRHAGE 1 0.0009
372 CEREBRAL VENTRICLE DILATATION 1 0.0009
373 CARDIO-RESPIRATORY ARREST 36 0.0009
374 HYPOVOLAEMIA 5 0.0009
375 SINUS TACHYCARDIA 12 0.0008
376 NEUROLEPTIC MALIGNANT SYNDROME 10 0.0008
377 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 2 0.0008
378 ATELECTASIS 8 0.0008
379 CYANOSIS 13 0.0008
380 VENTRICULAR ARRHYTHMIA 3 0.0008
381 DRUG INTERACTION 128 0.0008
382 SMALL FOR DATES BABY 4 0.0008
383 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
384 BLOOD BILIRUBIN ABNORMAL 1 0.0008
385 RENAL FAILURE ACUTE 33 0.0008
386 BLOOD CHLORIDE DECREASED 2 0.0008
387 FOETAL EXPOSURE DURING PREGNANCY 63 0.0008
388 VENTRICULAR EXTRASYSTOLES 8 0.0008
389 ANAEMIA POSTOPERATIVE 1 0.0008
390 DRUG CLEARANCE DECREASED 1 0.0008
391 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
392 BLOOD LACTIC ACID INCREASED 4 0.0008
393 PULMONARY OEDEMA 34 0.0008
394 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
395 ANGIONEUROTIC OEDEMA 2 0.0007
396 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
397 POST-TRAUMATIC STRESS DISORDER 5 0.0007
398 EMOTIONAL DISTRESS 89 0.0007
399 PERIPHERAL ISCHAEMIA 3 0.0007
400 CARBON DIOXIDE INCREASED 1 0.0007
401 EXPOSURE DURING PREGNANCY 45 0.0007
402 BILIARY TRACT DISORDER 1 0.0007
403 RASH MORBILLIFORM 2 0.0007
404 LEUKOCYTOSIS 13 0.0007
405 LIVE BIRTH 6 0.0007
406 CARDIOVERSION 1 0.0007
407 BRAIN OEDEMA 9 0.0007
408 BRONCHIAL OBSTRUCTION 1 0.0007
409 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
410 PURULENT DISCHARGE 3 0.0007
411 RESPIRATORY FAILURE 51 0.0007
412 IMMOBILE 3 0.0007
413 BLOOD POTASSIUM INCREASED 11 0.0007
414 EXCESSIVE EYE BLINKING 1 0.0007
415 BRAIN HERNIATION 2 0.0007
416 BLOOD CULTURE POSITIVE 2 0.0007
417 DRUG EFFECT DELAYED 3 0.0007
418 CRANIOCEREBRAL INJURY 2 0.0007
419 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
420 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
421 RENAL FAILURE CHRONIC 5 0.0006
422 GRAND MAL CONVULSION 6 0.0006
423 ATRIOVENTRICULAR BLOCK 5 0.0006
424 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
425 FUNGAEMIA 1 0.0006
426 DRUG EFFECT INCREASED 2 0.0006
427 ANTICHOLINERGIC SYNDROME 1 0.0006
428 POSTURE ABNORMAL 2 0.0006
429 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
430 TACHYCARDIA 54 0.0006
431 MUCOUS STOOLS 3 0.0006
432 OXYGEN SATURATION DECREASED 34 0.0006
433 PEPTIC ULCER 2 0.0006
434 CYTOLYTIC HEPATITIS 2 0.0006
435 HAEMODIALYSIS 5 0.0006
436 WRONG PRODUCT ADMINISTERED 4 0.0006
437 CLOSTRIDIAL INFECTION 2 0.0006
438 BODY TEMPERATURE INCREASED 12 0.0006
439 PHLEBITIS 3 0.0006
440 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
441 HYPOPNOEA 2 0.0006
442 EXTREMITY NECROSIS 1 0.0006
443 EXTRASYSTOLES 4 0.0006
444 ACUTE RESPIRATORY FAILURE 11 0.0006
445 CATATONIA 3 0.0006
446 BREAST DISCHARGE 1 0.0006
447 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
448 NECROTISING FASCIITIS 2 0.0006
449 ANAL FISSURE 3 0.0006
450 OVERWEIGHT 3 0.0006
451 CARDIOGENIC SHOCK 8 0.0006
452 APPARENT DEATH 2 0.0006
453 MONOCYTE COUNT INCREASED 2 0.0006
454 ESSENTIAL HYPERTENSION 1 0.0005
455 BLOOD UREA INCREASED 9 0.0005
456 AURA 1 0.0005
457 PROTEIN TOTAL DECREASED 2 0.0005
458 NEUROLOGICAL SYMPTOM 3 0.0005
459 TONGUE OEDEMA 2 0.0005
460 HYPERTONIA 3 0.0005
461 ARTERIAL DISORDER 1 0.0005
462 METABOLIC DISORDER 3 0.0005
463 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
464 RENAL TUBULAR NECROSIS 5 0.0005
465 RESPIRATORY ARREST 14 0.0005
466 DIPLEGIA 1 0.0005
467 GENE MUTATION 1 0.0005
468 PROTHROMBIN TIME PROLONGED 3 0.0005
469 FOETAL GROWTH RESTRICTION 3 0.0005
470 SHOCK HAEMORRHAGIC 4 0.0005
471 DRUG ABUSER 3 0.0005
472 CAPILLARY LEAK SYNDROME 1 0.0005
473 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
474 HEMIPLEGIA 4 0.0005
475 ACUTE MYOCARDIAL INFARCTION 14 0.0005
476 BUNDLE BRANCH BLOCK LEFT 2 0.0005
477 FOETAL DISTRESS SYNDROME 1 0.0005
478 UTERINE HAEMORRHAGE 2 0.0005
479 MYDRIASIS 6 0.0005
480 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
481 CD4 LYMPHOCYTES DECREASED 1 0.0005
482 BLOOD PRESSURE DECREASED 31 0.0005
483 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
484 DYSTONIA 9 0.0005
485 FACIAL PALSY 1 0.0005
486 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
487 ASPIRATION 5 0.0005
488 BIPOLAR I DISORDER 1 0.0005
489 PULMONARY CONGESTION 6 0.0005
490 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
491 CARDIAC FAILURE ACUTE 3 0.0004
492 CHOLESTATIC LIVER INJURY 1 0.0004
493 WRONG DRUG ADMINISTERED 4 0.0004
494 PRODUCT LABEL ISSUE 3 0.0004
495 PNEUMONIA ASPIRATION 11 0.0004
496 CONVULSION 25 0.0004
497 ISCHAEMIA 2 0.0004
498 SHOCK 10 0.0004
499 LARGE INTESTINE PERFORATION 3 0.0004
500 NEPHROGENIC ANAEMIA 2 0.0004
501 HYPERTRANSAMINASAEMIA 3 0.0004
502 POST PROCEDURAL HAEMORRHAGE 5 0.0004
503 BILIRUBIN CONJUGATED INCREASED 1 0.0004
504 PRE-ECLAMPSIA 2 0.0004
505 FAECAL INCONTINENCE 2 0.0004
506 EYE OEDEMA 1 0.0004
507 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
508 INJECTION SITE INFLAMMATION 2 0.0004
509 HYPERNATRAEMIA 2 0.0004
510 DERMATITIS EXFOLIATIVE 2 0.0004
511 RESPIRATORY DISTRESS 11 0.0004
512 TROPONIN INCREASED 3 0.0004
513 ABDOMINAL INFECTION 1 0.0004
514 DISSOCIATION 3 0.0004
515 MUSCLE TWITCHING 9 0.0004
516 CEREBRAL ISCHAEMIA 2 0.0004
517 EJECTION FRACTION DECREASED 6 0.0004
518 COMPARTMENT SYNDROME 1 0.0004
519 BLOOD POTASSIUM ABNORMAL 1 0.0004
520 MYASTHENIA GRAVIS 3 0.0004
521 ANAL ABSCESS 2 0.0004
522 ANXIETY 105 0.0004
523 HYDROCEPHALUS 2 0.0004
524 ESCHERICHIA INFECTION 3 0.0004
525 SEIZURE 42 0.0004
526 DEAFNESS UNILATERAL 2 0.0004
527 COAGULOPATHY 6 0.0004
528 COMA 17 0.0004
529 NEUTROPHILIA 2 0.0004
530 DUODENAL ULCER HAEMORRHAGE 1 0.0003
531 HYPERVENTILATION 2 0.0003
532 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
533 GASTROINTESTINAL NECROSIS 1 0.0003
534 DECREASED INTEREST 2 0.0003
535 CREPITATIONS 1 0.0003
536 RESPIRATORY DISORDER 10 0.0003
537 FIBROSIS 1 0.0003
538 LARYNGEAL OEDEMA 2 0.0003
539 HEPATIC ENCEPHALOPATHY 3 0.0003
540 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
541 EOSINOPHILIC PNEUMONIA 1 0.0003
542 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
543 PNEUMOTHORAX 5 0.0003
544 INTRAOCULAR PRESSURE INCREASED 4 0.0003
545 LOSS OF CONSCIOUSNESS 40 0.0003
546 PROCTALGIA 2 0.0003
547 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
548 HEPATITIS ACUTE 2 0.0003
549 MEDICATION ERROR 17 0.0003
550 SEDATION 8 0.0003
551 ASPERGILLUS INFECTION 2 0.0003
552 BRAIN INJURY 3 0.0003
553 CHOLECYSTITIS CHRONIC 2 0.0003
554 FACE OEDEMA 5 0.0003
555 POSTOPERATIVE WOUND INFECTION 2 0.0003
556 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
557 PALLOR 8 0.0003
558 BRONCHOPNEUMONIA 1 0.0003
559 DIFFICULTY IN WALKING 1 0.0003
560 BLOOD CREATININE ABNORMAL 1 0.0003
561 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
562 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
563 FIBRIN D DIMER INCREASED 1 0.0003
564 CONJUNCTIVAL HYPERAEMIA 1 0.0003
565 ISCHAEMIC STROKE 5 0.0003
566 BLOOD CREATININE INCREASED 18 0.0003
567 CUTANEOUS VASCULITIS 1 0.0003
568 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
569 CARDIOMYOPATHY 4 0.0003
570 HYPOPHOSPHATAEMIA 2 0.0003
571 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
572 HYDRONEPHROSIS 2 0.0003
573 BLOOD SODIUM DECREASED 5 0.0003
574 APHASIA 8 0.0003
575 HYPOCALCAEMIA 5 0.0003
576 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
577 HYPOALBUMINAEMIA 2 0.0003
578 CARDIOPULMONARY FAILURE 1 0.0003
579 BACTERAEMIA 3 0.0003
580 BLOOD ALBUMIN DECREASED 2 0.0003
581 MENTAL STATUS CHANGES 7 0.0003
582 CEREBRAL ATROPHY 1 0.0003
583 MIOSIS 2 0.0002
584 SENSORY LOSS 2 0.0002
585 DECUBITUS ULCER 2 0.0002
586 AGITATION 18 0.0002
587 ASPHYXIA 2 0.0002
588 POLYURIA 2 0.0002
589 ANAPHYLACTOID REACTION 1 0.0002
590 GENERALISED OEDEMA 3 0.0002
591 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
592 AORTIC DISSECTION 1 0.0002
593 GASTROINTESTINAL PERFORATION 1 0.0002
594 CONGESTIVE CARDIOMYOPATHY 1 0.0002
595 POISONING 3 0.0002
596 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
597 ABSCESS LIMB 1 0.0002
598 LIVER FUNCTION TEST INCREASED 5 0.0002
599 ABNORMAL SENSATION IN EYE 1 0.0002
600 ANURIA 2 0.0002
601 ARRHYTHMIA 11 0.0002
602 MYOPATHY 2 0.0002
603 DRUG INEFFECTIVE 304 0.0002
604 DELIRIUM 8 0.0002
605 DIVERTICULUM INTESTINAL 1 0.0002
606 INCORRECT PRODUCT STORAGE 3 0.0002
607 AMENORRHOEA 4 0.0002
608 SPINAL OSTEOARTHRITIS 2 0.0002
609 ABDOMINAL ABSCESS 1 0.0002
610 ANGIOEDEMA 10 0.0002
611 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
612 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
613 RASH MACULO-PAPULAR 5 0.0002
614 MYOSITIS 2 0.0002
615 DYSKINESIA 9 0.0002
616 DRUG TOXICITY 3 0.0002
617 AKATHISIA 3 0.0002
618 EYE OPERATION 1 0.0002
619 CONJUNCTIVITIS 4 0.0002
620 COORDINATION ABNORMAL 3 0.0002
621 PAIN IN JAW 6 0.0002
622 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
623 NERVOUSNESS 11 0.0002
624 URINARY RETENTION 7 0.0002
625 EYE INFLAMMATION 2 0.0002
626 GAIT INABILITY 7 0.0002
627 MYELODYSPLASTIC SYNDROME 3 0.0002
628 ENTEROCOCCAL INFECTION 1 0.0002
629 FLUID OVERLOAD 3 0.0002
630 DRUG EFFECT DECREASED 11 0.0002
631 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
632 PULMONARY MASS 3 0.0002
633 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
634 CORONARY ARTERY STENOSIS 1 0.0002
635 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
636 HYPOTHERMIA 2 0.0002
637 HAEMATEMESIS 5 0.0002
638 CARDIOVASCULAR DISORDER 5 0.0002
639 FEMORAL NECK FRACTURE 1 0.0002
640 ENDOCARDITIS 1 0.0002
641 EAR DISCOMFORT 2 0.0002
642 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
643 PERITONITIS 4 0.0002
644 DELUSION 3 0.0002
645 HYPERBILIRUBINAEMIA 2 0.0002
646 DRUG EFFECT INCOMPLETE 7 0.0002
647 FAILURE TO THRIVE 1 0.0002
648 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
649 PULMONARY HYPERTENSION 4 0.0002
650 HEART RATE INCREASED 19 0.0002
651 PRODUCT QUALITY ISSUE 26 0.0002
652 PAIN 116 0.0002
653 CARDIAC FAILURE 15 0.0002
654 MUSCLE TIGHTNESS 3 0.0002
655 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
656 DEPRESSION 42 0.0002
657 CHOKING SENSATION 1 0.0002
658 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
659 NERVE INJURY 2 0.0002
660 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
661 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
662 INTESTINAL PERFORATION 2 0.0002
663 PANCREATITIS ACUTE 4 0.0002
664 CHROMATURIA 4 0.0002
665 MITRAL VALVE INCOMPETENCE 2 0.0002
666 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
667 CARDIAC VALVE DISEASE 1 0.0002
668 PARANOIA 3 0.0002
669 CORONARY ARTERY BYPASS 1 0.0002
670 ELECTROLYTE IMBALANCE 2 0.0002
671 NEUROTOXICITY 3 0.0002
672 EOSINOPHILIA 3 0.0002
673 HEART RATE DECREASED 6 0.0002
674 MYALGIA 29 0.0002
675 BRADYKINESIA 1 0.0002
676 ATAXIA 2 0.0002
677 CARDIAC PACEMAKER INSERTION 1 0.0002
678 CEREBRAL HAEMORRHAGE 6 0.0002
679 BLOOD PRESSURE FLUCTUATION 4 0.0002
680 ADRENAL INSUFFICIENCY 2 0.0002
681 ATRIAL FIBRILLATION 16 0.0002
682 DRUG ADMINISTRATION ERROR 5 0.0002
683 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
684 CHOLANGITIS 1 0.0002
685 EXTRAPYRAMIDAL DISORDER 4 0.0002
686 SEPTIC SHOCK 7 0.0002
687 TOXICITY TO VARIOUS AGENTS 27 0.0002
688 DYSARTHRIA 6 0.0002
689 PULMONARY EMBOLISM 15 0.0002
690 RASH GENERALISED 4 0.0002
691 LACTIC ACIDOSIS 5 0.0002
692 DISABILITY 3 0.0002
693 DISORIENTATION 6 0.0002
694 HAEMATOCRIT DECREASED 3 0.0002
695 LIP SWELLING 5 0.0001
696 MUSCULAR WEAKNESS 17 0.0001
697 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
698 ACUTE HEPATIC FAILURE 2 0.0001
699 HYPERTENSION 31 0.0001
700 ERYTHEMA 30 0.0001
701 CORONARY ARTERY OCCLUSION 2 0.0001
702 SEPSIS 16 0.0001
703 HYPOKINESIA 2 0.0001
704 ACUTE KIDNEY INJURY 21 0.0001
705 BLINDNESS TRANSIENT 1 0.0001
706 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
707 STEVENS-JOHNSON SYNDROME 3 0.0001
708 THROMBOCYTOPENIA 15 0.0001
709 HAEMORRHAGE INTRACRANIAL 2 0.0001
710 ECONOMIC PROBLEM 2 0.0001
711 BOWEL MOVEMENT IRREGULARITY 1 0.0001
712 HYPOKALAEMIA 6 0.0001
713 DEVICE RELATED INFECTION 2 0.0001
714 FOOD ALLERGY 1 0.0001
715 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
716 PRODUCT USE COMPLAINT 2 0.0001
717 DRUG SCREEN POSITIVE 1 0.0001
718 FURUNCLE 1 0.0001
719 ATRIAL FLUTTER 1 0.0001
720 SENSORY DISTURBANCE 2 0.0001
721 CEREBRAL INFARCTION 3 0.0001
722 CHOLELITHIASIS 4 0.0001
723 ABASIA 3 0.0001
724 DRUG LEVEL INCREASED 2 0.0001
725 ACUTE CORONARY SYNDROME 1 0.0001
726 EOSINOPHIL COUNT INCREASED 1 0.0001
727 WHEEZING 7 0.0001
728 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
729 SKIN ULCER 3 0.0001
730 CARDIAC MURMUR 1 0.0001
731 JOINT STIFFNESS 3 0.0001
732 LYMPHOCYTE COUNT DECREASED 2 0.0001
733 HYPERSENSITIVITY 21 0.0001
734 JAUNDICE 3 0.0001
735 OVERDOSE 24 0.0001
736 BONE DISORDER 2 0.0001
737 ACCIDENTAL OVERDOSE 4 0.0001
738 TINNITUS 5 0.0001
739 HYPERHIDROSIS 14 0.0001
740 BACTERIAL INFECTION 2 0.0001
741 HEPATIC FUNCTION ABNORMAL 4 0.0001
742 CONDITION AGGRAVATED 32 0.0001
743 PROTEINURIA 2 0.0001
744 SLEEP APNOEA SYNDROME 2 0.0001
745 HYPERSOMNIA 3 0.0001
746 CHOLESTASIS 2 0.0001
747 MYOCARDIAL INFARCTION 18 0.0001
748 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
749 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
750 EMBEDDED DEVICE 1 0.0001
751 BLOOD PRESSURE ABNORMAL 2 0.0001
752 CEREBROVASCULAR ACCIDENT 17 0.0001
753 PREGNANCY 2 0.0001
754 BLOOD POTASSIUM DECREASED 3 0.0001
755 EMPHYSEMA 1 0.0001
756 DEATH 85 0.0001
757 PLEURAL EFFUSION 6 0.0001
758 DRY THROAT 1 0.0001
759 MUSCLE SPASMS 18 0.0001
760 RIB FRACTURE 2 0.0001
761 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
762 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
763 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
764 DEEP VEIN THROMBOSIS 6 0.0001
765 OEDEMA 5 0.0001
766 BIPOLAR DISORDER 1 0.0001
767 MENTAL DISORDER 4 0.0001
768 MUSCULOSKELETAL STIFFNESS 8 0.0001
769 DENTAL CARIES 1 0.0001
770 TRANSAMINASES INCREASED 2 0.0001
771 URTICARIA 15 0.0001
772 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
773 THERAPY NON-RESPONDER 4 0.0001
774 FISTULA 1 0.0001
775 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
776 HEART RATE IRREGULAR 2 0.0001
777 DERMATITIS CONTACT 1 0.0001
778 HAEMATURIA 3 0.0001
779 CARDIAC FAILURE CONGESTIVE 7 0.0001
780 PYREXIA 30 0.0001
781 EYELID OEDEMA 1 0.0001
782 RASH MACULAR 3 0.0001
783 COVID-19 PNEUMONIA 1 0.0001
784 TREATMENT FAILURE 7 0.0001
785 SOMNOLENCE 17 0.0001
786 PRODUCT PRESCRIBING ERROR 2 0.0001
787 MYELOSUPPRESSION 3 0.0001
788 DIABETIC KETOACIDOSIS 2 0.0001
789 HYPOGLYCAEMIA 4 0.0001
790 CYTOPENIA 1 0.0001
791 CARDIOMEGALY 1 0.0001
792 AGGRESSION 4 0.0001
793 HALLUCINATION 6 0.0001
794 CELLULITIS 4 0.0001
795 INTENTIONAL OVERDOSE 5 0.0001
796 DRUG RESISTANCE 2 0.0001
797 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
798 SWELLING FACE 5 0.0001
799 BEDRIDDEN 1 0.0001
800 GASTRITIS 2 0.0001
801 DYSMENORRHOEA 1 0.0001
802 CONFUSIONAL STATE 12 0.0001
803 BLOOD BILIRUBIN INCREASED 2 0.0001
804 LIMB INJURY 2 0.0001
805 BLINDNESS 3 0.0001
806 PNEUMONITIS 2 0.0001
807 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
808 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
809 PROCEDURAL PAIN 2 0.0001
810 PANCYTOPENIA 4 0.0001
811 BLISTER 4 0.0001
812 HYPONATRAEMIA 4 0.0001
813 BLINDNESS UNILATERAL 1 0.0001
814 DIALYSIS 1 0.0001
815 HAEMOGLOBIN DECREASED 7 0.0001
816 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
817 URINARY INCONTINENCE 2 0.0001
818 HEPATIC FAILURE 2 0.0001
819 CORONARY ARTERY DISEASE 2 0.0001
820 THERAPEUTIC RESPONSE DECREASED 4 0.0001
821 DEVICE FAILURE 1 0.0001
822 GYNAECOMASTIA 2 0.0001
823 ANKLE FRACTURE 1 0.0001
824 RENAL DISORDER 3 0.0001
825 CARDIAC DISORDER 6 0.0001
826 NERVOUS SYSTEM DISORDER 2 0.0001
827 SWOLLEN TONGUE 2 0.0001
828 RASH ERYTHEMATOUS 3 0.0001
829 ABSCESS 1 0.0001
830 HYPOTHYROIDISM 2 0.0001
831 MOVEMENT DISORDER 2 0.0001
832 RASH 27 0.0001
833 IMPAIRED HEALING 2 0.0001
834 EYE DISORDER 2 0.0001
835 STAPHYLOCOCCAL INFECTION 2 0.0001
836 FUNGAL INFECTION 2 0.0001
837 LEUKOPENIA 3 0.0001
838 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
839 SINUSITIS 6 0.0001
840 ANAEMIA 11 0.0001
841 OEDEMA PERIPHERAL 7 0.0001
842 COLD SWEAT 1 0.0001
843 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
844 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
845 PLATELET COUNT DECREASED 6 0.0001
846 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
847 OFF LABEL USE 49 0.0001
848 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
849 COMPLICATION OF DEVICE REMOVAL 1 0.0001
850 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
851 CRYING 2 0.0001
852 HYPERGLYCAEMIA 2 0.0001
853 PANIC ATTACK 2 0.0001
854 END STAGE RENAL DISEASE 1 0.0001
855 RESTLESSNESS 2 0.0001
856 BLOOD GLUCOSE ABNORMAL 1 0.0001
857 OROPHARYNGEAL PAIN 5 0.0001
858 ASTHENIA 20 0.0001
859 BLOOD URINE PRESENT 1 0.0001
860 ERUCTATION 1 0.0001
861 CHOKING 1 0.0001
862 SYNCOPE 5 0.0000
863 ABORTION SPONTANEOUS 2 0.0000
864 CYTOKINE RELEASE SYNDROME 1 0.0000
865 DYSPNOEA 28 0.0000
866 ILL-DEFINED DISORDER 3 0.0000
867 BONE MARROW FAILURE 1 0.0000
868 POLLAKIURIA 2 0.0000
869 WITHDRAWAL SYNDROME 2 0.0000
870 OSTEOARTHRITIS 2 0.0000
871 EATING DISORDER 1 0.0000
872 FAECES DISCOLOURED 1 0.0000
873 PRODUCT STORAGE ERROR 4 0.0000
874 LIVER DISORDER 2 0.0000
875 SUICIDAL IDEATION 4 0.0000
876 NEPHROLITHIASIS 2 0.0000
877 SKIN DISCOLOURATION 2 0.0000
878 ADVERSE EVENT 4 0.0000
879 PNEUMONIA 14 0.0000
880 BACK PAIN 10 0.0000
881 COGNITIVE DISORDER 2 0.0000
882 COUGH 12 0.0000
883 CHILLS 5 0.0000
884 TREMOR 7 0.0000
885 DYSPHAGIA 4 0.0000
886 PRODUCTIVE COUGH 2 0.0000
887 INFECTION 6 0.0000
888 FIBROMYALGIA 1 0.0000
889 LUNG DISORDER 2 0.0000
890 EPISTAXIS 3 0.0000
891 HYPOAESTHESIA 6 0.0000
892 CHRONIC KIDNEY DISEASE 3 0.0000
893 WEIGHT DECREASED 11 0.0000
894 ERECTILE DYSFUNCTION 1 0.0000
895 ABDOMINAL DISTENSION 4 0.0000
896 HAEMORRHAGE 4 0.0000
897 SPEECH DISORDER 2 0.0000
898 CHEST PAIN 7 0.0000
899 BREAST CANCER FEMALE 1 0.0000
900 THROMBOSIS 3 0.0000
901 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
902 COMPLETED SUICIDE 3 0.0000
903 FEELING COLD 1 0.0000
904 ANGINA PECTORIS 1 0.0000
905 LETHARGY 2 0.0000
906 INTENTIONAL PRODUCT MISUSE 3 0.0000
907 DYSSTASIA 1 0.0000
908 PALPITATIONS 4 0.0000
909 ASCITES 1 0.0000
910 SUICIDE ATTEMPT 2 0.0000
911 EPILEPSY 1 0.0000
912 EMOTIONAL DISORDER 1 0.0000
913 BONE DENSITY DECREASED 1 0.0000
914 BLOOD GLUCOSE INCREASED 6 0.0000
915 INFUSION RELATED REACTION 2 0.0000
916 FEBRILE NEUTROPENIA 2 0.0000
917 FALL 10 0.0000
918 ANGER 1 0.0000
919 FLUSHING 3 0.0000
920 URINARY TRACT INFECTION 5 0.0000
921 MEMORY IMPAIRMENT 4 0.0000
922 COVID-19 5 0.0000
923 C-REACTIVE PROTEIN INCREASED 1 0.0000
924 UNDERDOSE 2 0.0000
925 DYSURIA 1 0.0000
926 EYE SWELLING 1 0.0000
927 PRODUCT USE ISSUE 5 0.0000
928 HOT FLUSH 2 0.0000
929 DIABETES MELLITUS 2 0.0000
930 BLOOD PRESSURE INCREASED 4 0.0000
931 DIZZINESS 13 0.0000
932 ABDOMINAL PAIN 6 0.0000
933 VOMITING 12 0.0000
934 ABNORMAL BEHAVIOUR 1 0.0000
935 EXTRA DOSE ADMINISTERED 1 0.0000
936 ABDOMINAL PAIN UPPER 5 0.0000
937 BALANCE DISORDER 2 0.0000
938 DEVICE DISLOCATION 1 0.0000
939 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
940 DRUG WITHDRAWAL SYNDROME 2 0.0000
941 GASTROINTESTINAL DISORDER 2 0.0000
942 ADVERSE DRUG REACTION 2 0.0000
943 NO ADVERSE EVENT 4 0.0000
944 FATIGUE 17 0.0000
945 BLOOD CHOLESTEROL INCREASED 1 0.0000
946 SWELLING 2 0.0000
947 MIGRAINE 2 0.0000
948 PRURITUS 8 0.0000
949 MALAISE 9 0.0000
950 PAIN IN EXTREMITY 6 0.0000
951 DRY EYE 1 0.0000
952 FLUID RETENTION 1 0.0000
953 CHEST DISCOMFORT 2 0.0000
954 ECZEMA 1 0.0000
955 PARAESTHESIA 3 0.0000
956 NAUSEA 15 0.0000
957 DEPRESSED MOOD 1 0.0000
958 ARTHROPATHY 1 0.0000
959 EYE PAIN 1 0.0000
960 ASTHMA 2 0.0000
961 DYSPHONIA 1 0.0000
962 DISEASE PROGRESSION 2 0.0000
963 CATARACT 1 0.0000
964 JOINT SWELLING 2 0.0000
965 DISCOMFORT 1 0.0000
966 VISUAL IMPAIRMENT 2 0.0000
967 GAIT DISTURBANCE 3 0.0000
968 AMNESIA 1 0.0000
969 DEVICE DIFFICULT TO USE 1 0.0000
970 DEHYDRATION 2 0.0000
971 NEUTROPENIA 2 0.0000
972 VISION BLURRED 2 0.0000
973 BURNING SENSATION 1 0.0000
974 DEVICE MALFUNCTION 1 0.0000
975 CONSTIPATION 3 0.0000
976 BRONCHITIS 1 0.0000
977 DYSGEUSIA 1 0.0000
978 WEIGHT INCREASED 3 0.0000
979 DECREASED APPETITE 3 0.0000
980 DRUG DEPENDENCE 2 0.0000
981 DIARRHOEA 8 0.0000
982 DRY MOUTH 1 0.0000
983 ARTHRALGIA 5 0.0000
984 DRUG ABUSE 1 0.0000
985 ABDOMINAL DISCOMFORT 2 0.0000
986 HEADACHE 7 0.0000
987 DEVICE ISSUE 1 0.0000
988 NASOPHARYNGITIS 2 0.0000
989 CONTUSION 1 0.0000
990 DRUG INTOLERANCE 1 0.0000
991 DYSPEPSIA 1 0.0000
992 INCORRECT DOSE ADMINISTERED 2 0.0000
993 FEELING ABNORMAL 2 0.0000
994 ALOPECIA 1 0.0000